Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: A pilot study Journal Article


Authors: Youngster, I.; Eshel, A.; Geva, M.; Danylesko, I.; Henig, I.; Zuckerman, T.; Fried, S.; Yerushalmi, R.; Shem-Tov, N.; Fein, J. A.; Bomze, D.; Shimoni, A.; Koren, O.; Shouval, R.; Nagler, A.
Article Title: Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: A pilot study
Abstract: Acute graft-versus-host disease (aGvHD) is a serious complication of allogeneic hematopoietic stem-cell transplantation with limited treatment options. The gut microbiome plays a critical role in aGvHD pathogenesis. Fecal microbiota transplantation (FMT) has emerged as a potential therapeutic approach to restore gut microbial diversity. In this prospective pilot study, 21 patients with steroid-resistant or steroid-dependent lower gastrointestinal aGvHD received FMT in capsule form. At 28 days after the first FMT, the overall response rate was 52.4%, with 23.8% complete and 28.6% partial responses. However, sustained responses were infrequent, with only one patient remaining aGvHD-free long-term. FMT was generally well-tolerated. Microbiome analysis revealed dysbiosis in pre-FMT patient stool samples, with distinct microbial characteristics compared to donors. Following FMT, there was an increase in beneficial Clostridiales and a decrease in pathogenic Enterobacteriales. These findings highlight the potential of FMT as a treatment option for steroid-resistant aGvHD. Trial registration number NCT #03214289. © The Author(s), under exclusive licence to Springer Nature Limited 2024.
Keywords: adult; clinical article; controlled study; nonhuman; prospective study; prospective studies; steroid; hematopoietic stem cell transplantation; acute graft versus host disease; pilot study; pilot projects; patient safety; graft versus host reaction; gastrointestinal tract; graft vs host disease; steroids; overall response rate; lower gastrointestinal tract; microbiome; clostridiales; humans; human; male; female; article; fecal microbiota transplantation; dysbiosis; enterobacterales
Journal Title: Bone Marrow Transplantation
Volume: 59
Issue: 3
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2024-03-01
Start Page: 409
End Page: 416
Language: English
DOI: 10.1038/s41409-024-02198-2
PUBMED: 38212672
PROVIDER: scopus
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding author is MSK authors: Roni Shouval -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Roni Shouval
    151 Shouval